61
Views
5
CrossRef citations to date
0
Altmetric
Original

Expression of SIP24 in the Peripartum and Postpartum Rat Uterus

, , &
Pages 235-241 | Received 26 Aug 2005, Accepted 09 Sep 2005, Published online: 06 Aug 2009
 

Abstract

SIP24 is, a 24 kDa superinducible protein, is an acute phase protein that is expressed in several tissues and organs and is identified in the human, mouse, and rat genome as lipocalin 2 (lcn2). This study investigated SIP24 expression by the rat uterus just before delivery and during postpartum involution. The distribution and levels of expression of SIP24 and myeloperoxidase (MPO) were compared by Western blot analysis and immunocytochemistry. The SIP24 level was high on day 22 of pregnancy and on days 1 and 2 postpartum, decreased on day 3 postpartum, and declined to low levels similar to those in nonpregnant rats by day 5 postpartum. SIP24 positive cells were identified by immunohistochemistry in the luminal and glandular epithelium on day 22 of pregnancy and on days 1, 2, 3, and 5 postpartum in addition to nonpregnant rats. Immunostaining was intense on day 22 of pregnancy and on days 1 and 2 postpartum. MPO also was identified in uterine tissues by immunohistochemistry. An evaluation of the SIP24 and MPO distribution and levels of expression in the rat uterus is consistent with the hypothesis that SIP24 modulates the neutrophil population by activities such as inducing their apoptosis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.